Pulmonx Corp. (LUNG)
NASDAQHealth CareMedical - DevicesSnapshot 2026-11-05
$2.56-9.54%
Close 2026-11-05 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-11-05
QuarterlyIQ Insights · LUNG
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenues | 88.8 | 90.5 | 83.8 | 68.7 | 53.7 | 48.4 | 32.7 |
| Cost of Revenues | 20.0 | 23.4 | 21.8 | 17.9 | 13.8 | 12.8 | 11.5 |
| Gross Profit | 68.7 | 67.1 | 62.0 | 50.8 | 39.9 | 35.6 | 21.2 |
| Operating Expenses & Income | |||||||
| Selling, General & Admin | 88.8 | 101.3 | 102.1 | 94.6 | 83.1 | 69.9 | 46.1 |
| R&D Expenses | 19.4 | 19.5 | 17.6 | 18.1 | 15.4 | 13.1 | 7.5 |
| Operating Income | (39.4) | (53.7) | (57.7) | (61.9) | (58.6) | (47.3) | (32.3) |
| Earnings from Continuing Operations | |||||||
| Interest Expense | — | 3.2 | 3.5 | 3.2 | 1.1 | 0.8 | 3.2 |
| Interest & Investment Income | 1.5 | 2.7 | 5.1 | 5.6 | 1.5 | 0.4 | 0.2 |
| Net Interest Expenses | — | — | — | (2.3) | (0.5) | 0.4 | 3.0 |
| EBT, Incl. Unusual Items | (41.9) | (53.4) | (55.9) | (60.3) | (58.6) | (48.3) | (32.0) |
| Income Tax Expense | 0.6 | 0.6 | 0.5 | 0.6 | 0.4 | 0.3 | 0.2 |
| Net Income | |||||||
| Net Income | (42.6) | (54.0) | (56.4) | (60.8) | (58.9) | (48.7) | (32.2) |
| Per Share | |||||||
| Basic EPS | (0.99) | (1.33) | (1.44) | (1.60) | (1.59) | (1.35) | (3.16) |
| Diluted EPS | (0.99) | (1.33) | (1.44) | (1.60) | (1.59) | (1.35) | (3.16) |
| Revenue per Share | 2.06 | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 43.2 | 40.7 | 39.1 | 38.0 | 37.1 | 36.1 | 10.2 |
| Diluted Weighted Avg Shares | 43.2 | 40.7 | 39.1 | 38.0 | 37.1 | 36.1 | 10.2 |
| Supplemental | |||||||
| EBIT | (39.4) | (53.7) | (57.7) | (61.9) | (58.6) | (47.3) | (32.3) |
| Effective Tax Rate | -1.5% | — | — | -0.9% | -0.6% | -0.7% | -0.7% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.